Documents
Application Sponsors
NDA 215668 | DR REDDYS LABS LTD | |
Marketing Status
Application Products
001 | SOLUTION;INTRAVENOUS | 100MG/4ML (25MG/ML) | 0 | BENDAMUSTINE HYDROCHLORIDE | BENDAMUSTINE HYDROCHLORIDE |
FDA Submissions
TYPE 5; Type 5 - New Formulation or New Manufacturer | ORIG | 1 | TA | 2021-11-12 | STANDARD |
Submissions Property Types
CDER Filings
Accessdata Error
cder:Array
(
[0] => Array
(
[ApplNo] => 215668
[companyName] => Accessdata Error
[docInserts] => ["",""]
[products] => []
[labels] =>
[originalApprovals] => []
[supplements] =>
[actionDate] => 0000-00-00
)
)